New incubator kicks off with cacncer 'suicide' company

BioElf, the Exeter University based technology transfer company, has recently launched its first company, Exeter Antioxidant Therapeutics Ltd (EATL). The team at Exeter University and the Royal Devon and Exeter Hospital has developed biocatalysts which make cancer cells 'commit suicide'. The company is also developing novel decontamination methods for medical instruments. BioElf has formed a board of directors for EATL, and has a funding plan with an initial target of £3.5m. The funds will be used for the development and evaluation of the catalytic compounds, performing clinical trials, setting up a manufacturing capability and forming partnerships.BioElf was set up in June 2003 by a partnership of the Universities of Exeter and Plymouth, the new Peninsula Medical School, Plymouth Marine Laboratory and the major NHS Trusts in the South West of England, to manage and exploit intellectual property in the biotech and healthcare fields. It provides expertise, management skills and advice to develop research ideas into saleable products and services.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• UK / Ireland
• Healthcare